Clinical Trials Browser

Phase 1/2 × NIH × BAY 1895344 × Clear all

NCT05071209 2026-01-23

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Phase 1/2 Active not recruiting

31 enrolled 14 charts

LymphoidSarcoma

Lymphoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar